Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul-Aug;20(4):436-41.
doi: 10.15274/INR-2014-10042. Epub 2014 Aug 28.

Use of the pipeline embolization device to treat recently ruptured dissecting cerebral aneurysms

Affiliations

Use of the pipeline embolization device to treat recently ruptured dissecting cerebral aneurysms

Robert S K Chan et al. Interv Neuroradiol. 2014 Jul-Aug.

Abstract

The Pipeline embolization device (PED) is one of the flow-diverting stents approved for the treatment of unruptured large or wide-necked cerebral aneurysms in 2011(1). Its use has now been extended to the treatment of recently ruptured dissecting cerebral aneurysm, carotid pseudoaneurysm from radiation injury, and blister aneurysms(2,3). We aimed to evaluate the effectiveness of utilizing the PED as a primary treatment for ruptured dissecting intracranial aneurysms. A single center retrospective review was conducted for all patients primarily treated with PED for acute subarachnoid hemorrhage (SAH) from ruptured dissecting cerebral aneurysms between December 2010 and February 2013. Patients were followed up with CT angiogram (CTA) or digital subtraction angiogram (DSA). Eight patients with a total of eight dissecting aneurysms were identified. The mean duration from SAH to treatment was 2.5 days. Six of the aneurysms arose from vertebral arteries and two from the basilar artery. Immediate check-DSA confirmed satisfactory contrast stasis in all eight cases, and complete aneurysmal obliteration was achieved at six months. There were two (25%) procedure-related complications, but no major procedure-related complications, such as thromboembolic events or rebleeding from aneurysm were encountered. The PED is a feasible treatment option for ruptured dissecting cerebral aneurysms in acute phase. According to our experience, using PED as flow-diverters in acute SAH does not significantly increase the complication risks or mortality rate if the antiplatelet regime is carefully monitored. Future studies shall evaluate the optimal antiplatelet regimen for using the PED in the acute phase.

Keywords: VerifyNow assay; dissecting aneurysms; pipeline embolization device; subarachnoid hemorrhage.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A) Pre-stenting of a right vertebral artery dissecting aneurysm, with posterior inferior cerebellar artery involvement. B) Immediate angiogram after stenting of the right vertebral artery. C) 4 months post-stenting of the right vertebral artery, showing satisfactory aneurysmal obliteration with patency of the posterior inferior cerebellar artery.

Similar articles

Cited by

References

    1. Fischer S, Vajda Z, Aguilar Perez M, et al. Pipeline embolization device (PED) for neurovascular reconstruction: initial experience in the treatment of 101 intracranial aneurysms and dissections. Neuroradiology. 2012;54(4):369–382. doi: 10.1007/s00234-011-0948-x. - DOI - PMC - PubMed
    1. Martin AR, Cruz JP, Matouk CC, et al. The pipeline flow-diverting stent for exclusion of ruptured intracranial aneurysms with difficult morphologies. Neurosurgery. 2012;70(1 Suppl Operative):21–28. discussion 28. - PubMed
    1. Rasskazoff S, Silvaggio J, Brouwer PA, et al. Endovascular treatment of a ruptured blood blister-like aneurysm with a flow-diverting stent. Interv Neuroradiol. 2010;16(3):255–258. - PMC - PubMed
    1. Augsburger L, Farhat M, Reymond P, et al. Effect of flow diverter porosity on intraaneurysmal blood flow. Klin Neuroradiol. 2009;19(3):204–214. doi: 10.1007/s00062-009-9005-0. - DOI - PubMed
    1. Kallmes DF, Ding YH, Dai D, et al. A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke. 2007;38(8):2346–2352. doi: 10.1161/STROKEAHA.106.479576. - DOI - PubMed

MeSH terms

LinkOut - more resources